Success for Glaxo’s 3D mark for purple asthma inhaler
Glaxo has prevailed on appeal in these long-running invalidity proceedings, with the General Court annulling a EUIPO decision invalidating Glaxo’s 3D mark for the shape of an inhaler.
Glaxo has prevailed on appeal in these long-running invalidity proceedings, with the General Court annulling a EUIPO decision invalidating Glaxo’s 3D mark for the shape of an inhaler.
Confusion may still occur where similar marks are applied to pharmaceutical products prescribed by doctors and dispensed by pharmacists.
A year on from the USPTO's domicile rule change, new data shows the leading China-based representatives on trademark applications at the agency.
31 July 2020
The business opportunities created by the coronavirus pandemic have led many pharmaceutical companies worldwide to file for trademarks containing the word ‘corona’. In India, there are 25 pending applications for such marks in Class 5, all of which were filed between March and June 2020.
31 July 2020
NAM has issued a report on the scale of the counterfeits industry and proposed radical changes to the ways in which the private and public sectors combat the trade in fake goods.
29 July 2020
In our latest round-up, we look at how American consumers are changing their brand preferences during covid-19, a bid for the Brooks Brothers brand, the Beijing IP Court invalidating a 3D trademark, and much more.
28 July 2020
In an action for the revocation of the domain name ‘multimed.cl’, filed by the owner of the trademark MULTIMED, the Ordinary Court of Appeals has held that a domain name is the projection of a trademark in the digital environment, where their functions are linked.
28 July 2020
WTR can now reveal more speakers to our upcoming WTR Connect event, including experts from Amazon, ASOS, Dyson, Gilead, Jack Daniels, SuperDry and Walmart.
27 July 2020
Analysis of the stock market performance of the WTR Brand Elite – a composite index of some of the world’s top brand-focused companies – since the start of 2018 paints a largely positive picture.
23 July 2020
Although some expected an opposition due to CORONIL misleading the public as a cure for covid-19, the order is the result of another mark claiming priority.
22 July 2020
The first week of July was the busiest the UKIPO has ever seen, putting to rest any fears that the coronavirus pandemic would have lasting effects on application levels.
17 July 2020
This decision of the EU General Court highlights the importance of consistently gathering proof of use, especially when this concerns use between economically-linked entities within the same group.
16 July 2020
Unlock unlimited access to all WTR content